Dr Lalchandani Labs Ltd - 541299 - Submission Of Cashflow Statement
Submission Of Cashflow Statement for Results for the Half-year ended 30th September 2019.16-12-2019
16-12-2019
Dr Lalchandani Labs Ltd - 541299 - Intimation Of Appointment Of Chief Financial Officer.
Mrs.Anchal Gupta has been appointed as a Chief Financial Officer of the Company with effect from 01st November 2019 in their meeting of Board of Directors held on Friday, 01st November 2019 at Registered Office of the company pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.16-12-2019
Dr Lalchandani Labs Ltd - 541299 - Intimation Of Appointment Of Chief Financial Officer.
Mrs.Anchal Gupta has been appointed as a Chief Financial Officer of the Company with effect from 01st November 2019 in their meeting of Board of Directors held on Friday, 01st November 2019 at Registered Office of the company pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.16-12-2019
Dr Lalchandani Labs Ltd - 541299 - Results - Unaudited Financial Results For The Half Year Ended September 30, 2019
In terms of the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Half Year ended on 30th September 2019 and other applicable provisions, we are pleased to submit the following documents:- 1. Unaudited Standalone Financial Results for the period ended September 30, 2019 2. Standalone Limited Review Report for the period ended September 30, 201911-11-2019
Dr Lalchandani Labs Ltd - 541299 - Outcome of Board Meeting
A meeting of the Board of Directors of the Company was held on Monday, 11th November 2019 at 04:00 pm at the Registered Office of the Company at M-20, Basement, Greater Kailash-1, New Delhi-110048. In the Board Meeting, the Board of Directors approved the following items: 1. Approval for Half Yearly Un-audited Financial Results of the Company as per the SEBI (LODR) Regulations, 2015.11-11-2019
Dr Lalchandani Labs Ltd - 541299 - Commencement Of Operations In Hyderabad And Bangalore.
Dr Lalchandani Labs Limited would like to inform you all that to meet the growing demand of the market and for serving more people, we have commenced our business operations in more well-known cities Hyderabad and Bangalore starting from the month of October 2019. As our vision of bringing quality health care to our society, we are happy to make the above-said announcement a step ahead towards our vision. This new business expansion will offer an extensive range of growth in the company.08-11-2019
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Intimation for Board Meeting Intimation For Notice Of Board Meeting To Consider Un-Audited Financial Results For The Half Year Ending 30Th September 2019.
Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2019 ,inter alia, to consider and approve Dr Lalchandani Labs Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11th November 2019, inter alia, to consider and approve: -To consider and approve Unaudited (Provisional) Financial Results of the Company for the Half Year ended 30th September 2019 along with Limited Review report. -Any other Business matter, with the permission of the Chair.01-11-2019
Dr Lalchandani Labs Ltd - 541299 - Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30Th September 2019.
Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30th September 2019.24-10-2019
Dr Lalchandani Labs Ltd - 541299 - Shareholding for the Period Ended September 30, 2019
Dr Lalchandani Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here15-10-2019
Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the Quarter ended September 30, 2019.15-10-2019